NYSE
Cardinal Health, Inc. (CAH)
♥ 726 Thanks from members
Cardinal Health (CAH) reported strong Q4 2026 results with 6% revenue growth to $63.7 billion and a 40% jump in non-GAAP diluted EPS to $2.91, driven by Pharmaceutical and Specialty Solutions, high-margin brand and generic performance, and a tariff refund benefit.